The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy

BACKGROUND/AIMS: Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control in type 2 diabetes, however, their influence on the retinal neurovascular unit remains unclear. METHODS: Vasculo- and neuroprotective effects were assessed in experimental diabetic retinopathy and high glucose-cultiva...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietrich, Nadine, Kolibabka, Matthias, Busch, Stephanie, Bugert, Petra, Kaiser, Ulrike, Lin, Jihong, Fleming, Thomas, Morcos, Michael, Klein, Thomas, Schlotterer, Andrea, Hammes, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152931/
https://www.ncbi.nlm.nih.gov/pubmed/27942008
http://dx.doi.org/10.1371/journal.pone.0167853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152931/
https://www.ncbi.nlm.nih.gov/pubmed/27942008
http://dx.doi.org/10.1371/journal.pone.0167853

Ejemplares similares